Use of glucagon-like peptide-1 receptor agonists in eating disorder populations.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Use of glucagon-like peptide-1 receptor agonists in eating disorder populations.
- Published In:
- The International journal of eating disorders, 57(2), 286-293 (2024)
- Authors:
- Bartel, Sara, McElroy, Susan L, Levangie, Danielle, Keshen, Aaron
- Database ID:
- RPEP-07822
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07822APA
Bartel, Sara; McElroy, Susan L; Levangie, Danielle; Keshen, Aaron. (2024). Use of glucagon-like peptide-1 receptor agonists in eating disorder populations.. The International journal of eating disorders, 57(2), 286-293. https://doi.org/10.1002/eat.24109
MLA
Bartel, Sara, et al. "Use of glucagon-like peptide-1 receptor agonists in eating disorder populations.." The International journal of eating disorders, 2024. https://doi.org/10.1002/eat.24109
RethinkPeptides
RethinkPeptides Research Database. "Use of glucagon-like peptide-1 receptor agonists in eating d..." RPEP-07822. Retrieved from https://rethinkpeptides.com/research/bartel-2024-use-of-glucagonlike-peptide1
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.